Part III. Drugs and Devices
- § 21–216. Adulterated Drugs and Devices
- § 21–217. Misbranded Drugs
- § 21–218. Additional Drug Misbranding Grounds
- § 21–218. Additional Drug Misbranding Grounds
- § 21–219. Exemptions to Labeling Requirements
- § 21–220. Prescription Required to Dispense Drugs
- § 21–220. Prescription Required to Dispense Drugs
- § 21–221. Prescription Drug Labeling
- § 21–222. Construction with Controlled Substance Laws
- § 21–223. Approved Applications Required to Sell, Give Away, or Deliver New Drugs
- § 21–224. Exemption of New Drugs from Application Requirements
- § 21–225. Access of Secretary to Records
- § 21–226. Printed Material Accompanying Packaging
- § 21–227. Requests by Secretary for Information
- § 21-228. Reserved
- § 21-229. Reserved